Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ben Ho
Observed names:
Ben L B Ho,
Ben L. B. Ho
Institution:
Hospital for Sick Children
Observed institutions:
University of Southern California,
University of Calgary,
University of California, San Francisco,
University of Toronto,
Great Ormond Street Hospital,
Hospital for Sick Children,
Children's Oncology Group,
California State University, Long Beach
show all 8
OpenAlex ID:
A5074092540
Molecular subgrouping of atypical teratoid/rhabdoid tumors—a reinvestigation and current consensus
2019
·
Ben Ho
, Pascal D Johann
, et al.
·
Neuro-Oncology
·
237
PDF
Efficacy of High-Dose Chemotherapy and Three-Dimensional Conformal Radiation for Atypical Teratoid/Rhabdoid Tumor: A Report From the Children’s Oncology Group Trial ACNS0333
2020
·
Alyssa T. Reddy
, Douglas R. Strother
, et al.
·
Journal of Clinical Oncology
·
198
The molecular landscape of ETMR at diagnosis and relapse
2019
·
Sander Lambo
, Susanne N. Gröbner
, et al.
·
Nature
·
145
Heterogeneity within the PF-EPN-B ependymoma subgroup
2018
·
Florence M. G. Cavalli
, Jens-Martin Hübner
, et al.
·
Acta Neuropathologica
·
129
Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry study
2019
·
Bryan K. Li
, Alexandre Vasiljevic
, et al.
·
Acta Neuropathologica
·
112
PDF
Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases
2020
·
Dörthe Holdhof
, Pascal D. Johann
, et al.
·
Acta Neuropathologica
·
93
PDF
DNA Polymerase and Mismatch Repair Exert Distinct Microsatellite Instability Signatures in Normal and Malignant Human Cells
2020
·
Jiil Chung
, Yosef E. Maruvka
, et al.
·
Cancer Discovery
·
87
A C19MC-LIN28A-MYCN Oncogenic Circuit Driven by Hijacked Super-enhancers Is a Distinct Therapeutic Vulnerability in ETMRs: A Lethal Brain Tumor
2019
·
Patrick Sin-Chan
, Iqra Mumal
, et al.
·
Cancer Cell
·
83
PDF
Diagnostic classification of childhood cancer using multiscale transcriptomics
2023
·
Federico Comitani
, Joshua O. Nash
, et al.
·
Nature Medicine
·
43
PDF
Atypical Teratoid Rhabdoid Tumour : From Tumours to Therapies
2018
·
Elizabeth Anne Richardson
, Ben Ho
, et al.
·
Journal of Korean Neurosurgical Society
·
41
PDF
Clinical phenotypes and prognostic features of embryonal tumours with multi-layered rosettes: a Rare Brain Tumor Registry study
2021
·
Sara Khan
, Palma Solano-Paez
, et al.
·
The Lancet Child & Adolescent Health
·
39
Advancing biology-based therapeutic approaches for atypical teratoid rhabdoid tumors
2020
·
Lindsey M Hoffman
, Elizabeth Anne Richardson
, et al.
·
Neuro-Oncology
·
39
PDF
Modeling germline mutations in pineoblastoma uncovers lysosome disruption-based therapy
2020
·
Philip E. D. Chung
, Deena M. A. Gendoo
, et al.
·
Nature Communications
·
36
PDF
Phase 3 randomized trial of high-dose methotrexate for young children with high-risk embryonal brain tumors: A report from the Children’s Oncology Group
2025
·
Claire Mazewski
, Sarah E S Leary
, et al.
·
Neuro-Oncology
·
24
Molecular Classification and Management of Rare Pediatric Embryonal Brain Tumors
2018
·
Patrick Sin-Chan
, Bryan K. Li
, et al.
·
Current Oncology Reports
·
23
Inhibiting EZH2 targets atypical teratoid rhabdoid tumor by triggering viral mimicry via both RNA and DNA sensing pathways
2024
·
Shengrui Feng
, Sajid A. Marhon
, et al.
·
Nature Communications
·
14
PDF
Reply to S.A. Upadhyaya
2020
·
Alyssa T. Reddy
, Mark D. Krailo
, et al.
·
Journal of Clinical Oncology
·
7
A kinome drug screen identifies multi-TKI synergies and ERBB2 signaling as a therapeutic vulnerability in MYC/TYR subgroup atypical teratoid rhabdoid tumors
2024
·
Brian Golbourn
, Ben Ho
, et al.
·
Neuro-Oncology
·
6
PDF
Infantile suprasellar tumor diagnosed as a pineoblastoma RB1 subgroup and treatment challenges: A pediatric SNO Molecular Tumor Board
2022
·
Jeffrey A Rubens
, Craig Erker
, et al.
·
Neuro-Oncology Advances
·
6
PDF
Sustained and durable response with Alisertib monotherapy in the treatment of relapsed Atypical Teratoid Rhabdoid Tumor (ATRT)
2022
·
Kaitlyn Howden
, Patrick J McDonald
, et al.
·
Neuro-Oncology Advances
·
5
PDF
Atrt-04. Correlation of Clinicopathologic Features and Cumulative Incidence of Relapse for Patients With Atypical Teratoid Rhabdoid Tumor on Acns0333: a Report From the Children’s Oncology Group
2021
·
Alyssa Reddy
, Jaclyn Biegel
, et al.
·
Neuro-Oncology
·
3
PDF
Corrigendum to: Molecular subgrouping of atypical teratoid/rhabdoid tumors—a reinvestigation and current consensus
2020
·
Ben Ho
, Pascal D Johann
, et al.
·
Neuro-Oncology
·
3
PDF
Path-24. Molecular Classification of High Risk Infant Embryonal Brain Tumors Enrolled in the Acns0334 Trial: a Report From the Children’s Oncology Group
2020
·
Bryan K Li
, Peter Burger
, et al.
·
Neuro-Oncology
·
3
PDF
Atrt-11. Molecular Subgroups of Atypical Teratoid/rhabdoid Tumor (atrt): Towards a Consensus
2018
·
Martin Hasselblatt
, Pascal D Johann
, et al.
·
Neuro-Oncology
·
2
PDF
Outcomes following radiotherapy for atypical teratoid/rhabdoid tumor in combination with surgery and intensive chemotherapy: A report from Children’s Oncology Group study ACNS0333
2025
·
Paul Aridgides
, Anita Mahajan
, et al.
·
Neuro-Oncology Pediatrics
·
1
PDF
Show more works
View as search
Works count:
41
Citation count:
1,380
H-index:
15
I10-index:
16
Year
Topic
Type